📣 VC round data is live. Check it out!

Genpact Valuation Multiples

Discover revenue and EBITDA valuation multiples for Genpact and similar public comparables like Teleperformance, L&T Technology Services, Sagility, Firstsource Solutions and more.

Genpact Overview

About Genpact

Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.


Founded

2007

HQ

India

Employees

140.0K

Financials (LTM)

Revenue: $5B
EBITDA: $964M

EV

$6B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Genpact Financials

Genpact reported last 12-month revenue of $5B and EBITDA of $964M.

In the same LTM period, Genpact generated $2B in gross profit, $964M in EBITDA, and $659M in net income.

Revenue (LTM)


Genpact P&L

In the most recent fiscal year, Genpact reported revenue of $5B and EBITDA of $934M.

Genpact is profitable as of last fiscal year, with gross margin of 36%, EBITDA margin of 18%, and net margin of 13%.

See analyst estimates for Genpact
LTMLast FY202320242025202620272028
Revenue$5B$5B$4B$5B$5B
Gross Profit$2B$2B$2B$2B$2B
Gross Margin36%36%35%35%36%
EBITDA$964M$934M$773M$853M$899M
EBITDA Margin18%18%17%18%18%
EBIT Margin18%17%14%15%15%
Net Profit$659M$645M$631M$514M$552M
Net Margin13%13%14%11%11%
Net Debt—$688M———

Financial data powered by Morningstar, Inc.

Genpact Stock Performance

Genpact has current market cap of $5B, and enterprise value of $6B.

Market Cap Evolution


Genpact's stock price is $29.05.

Genpact share price decreased by 16.4% in the last 30 days, and by 32.5% in the last year.

Genpact has an EPS (earnings per share) of $3.80.

See more trading valuation data for Genpact
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$6B$5B0.4%-16.4%-26.9%-32.5%$3.80

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Genpact Valuation Multiples

Genpact trades at 1.1x EV/Revenue multiple, and 6.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Genpact

EV / Revenue (LTM)


Genpact Financial Valuation Multiples

As of May 16, 2026, Genpact has market cap of $5B and EV of $6B.

Genpact has a P/E ratio of 7.5x.

LTMLast FY202320242025202620272028
EV/Revenue1.1x1.1x1.3x1.2x1.1x
EV/EBITDA6.0x6.2x7.4x6.7x6.4x
EV/EBIT6.3x6.5x9.2x8.2x7.6x
EV/Gross Profit3.0x3.1x3.7x3.4x3.1x
P/E7.5x7.6x7.8x9.6x8.9x
EV/FCF8.2x7.9x13.3x10.9x7.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Genpact Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Genpact Margins & Growth Rates

Genpact grew revenue by 7% and EBITDA by 9% in the last fiscal year.

In the most recent fiscal year, Genpact reported gross margin of 36%, EBITDA margin of 18%, and net margin of 13%.

See estimated margins and future growth rates for Genpact

Genpact Margins

Last FY202420252026202720282029
Gross Margin36%35%36%37%
EBITDA Margin18%18%18%19%
EBIT Margin17%15%15%18%
Net Margin13%11%11%13%
FCF Margin14%11%14%12%

Genpact Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth7%6%7%7%
Gross Profit Growth8%8%8%8%
EBITDA Growth9%10%5%13%
EBIT Growth8%12%8%26%
Net Profit Growth6%(19%)8%23%
FCF Growth(10%)23%37%(9%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Genpact Operational KPIs

Genpact's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.

Genpact's Rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Genpact's Rule of X is 36% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Genpact
LTMLast FY202320242025202620272028
Rule of 4026%26%———
Bessemer Rule of X36%36%———
Revenue per Employee—$0.0M———
Opex per Employee—$0.0M———
Opex to Revenue—21%21%21%21%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Genpact Competitors

Genpact competitors include Teleperformance, L&T Technology Services, Sagility, Firstsource Solutions, MyEG, Amano, Concentrix, eClerx Services, Jack Henry & Associates and Intertek.

Most Genpact public comparables operate across BPO Services.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Teleperformance0.8x0.8x3.9x3.9x
L&T Technology Services3.0x3.0x16.6x17.0x
Sagility2.8x2.7x10.9x10.9x
Firstsource Solutions1.9x1.9x12.0x11.7x
MyEG5.8x5.6x7.4x7.0x
Amano1.2x1.2x5.5x5.9x
Concentrix0.6x0.6x4.1x4.0x
eClerx Services3.1x3.0x11.2x12.1x

This data is available for Pro users. Sign up to see all Genpact competitors and their valuation data.

Start Free Trial

Genpact M&A Activity

Genpact has acquired 17 companies to date.

Last acquisition by Genpact was on June 5th 2025. Genpact acquired XponentL Data for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Genpact

XponentL Data
Enquero
Rightpoint
RiskCanvas Holdings
Description
XponentL Data is a technology consultancy delivering data engineering and AI solutions for enterprises in life sciences, healthcare, financial services, consumer packaged goods, industrial, and hospitality sectors. Services span data strategy development, AI model deployment, generative AI applications, intelligent data management platforms, and managed analytics operations. Boston-headquartered since its founding in 2020, XponentL Data builds custom data products and engineering pipelines for clients like pharmaceutical giants and global banks, emphasizing scalable infrastructure on cloud platforms such as AWS and Azure.
Enquero is a San Ramon-headquartered management consultancy focused on data engineering and analytics modernization. The firm delivers platforms for customer 360 views, AI-driven insights, and cloud migrations to financial services and retail clients across the United States.
Chicago-based Rightpoint delivers customer experience solutions to more than 250 Fortune 1000 companies via strategy consulting, website design and development, content management, CRM systems, e-commerce platforms, business intelligence tools, and cloud infrastructure services. Recognized among Crain's 50 Fastest Growing Companies in Chicago for four consecutive years, the agency maintains eight offices across the United States. Acquired by Infogain in 2021, Rightpoint combines technology expertise with design to transform client business operations through seamless digital experiences.
RiskCanvas Holdings is a provider of SaaS platforms and consulting for enterprise risk management headquartered in the United States. The integrated system maps operational, financial, and strategic risks, facilitates scenario modeling, and generates board-level reporting for Fortune 1000 companies in energy, manufacturing, and financial services.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
Philadelphia, PA
San Jose, CA
Chicago, IL
Washington, DC
Deal Date5 Jun 20255 Jan 202115 Oct 20198 Jan 2019
Valuationundisclosed$149M$271M$6M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Genpact acquisitions and their M&A valuation multiples.

Start Free Trial

Genpact Investment Activity

Genpact has invested in 1 company to date.

Latest investment by Genpact was on July 29th 2016. Genpact invested in Medinfi Healthcare in their $200K Angel round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Genpact

Medinfi Healthcare
Description
Medinfi Healthcare is a New Delhi-based platform connecting users to doctors and clinics across 31 cities in India. Its Android app and mobile website provide verified information on nearby healthcare providers for routine check-ups. The service features blogs by medical professionals covering health and lifestyle topics. Medinfi extends to hospital directories and appointment booking functionalities for urban and semi-urban populations.
HQ CountryIndia
HQ City
Bangalore
Deal Date29 Jul 2016
RoundAngel
Raised$200K
InvestorsEvan Lim; Genpact; Hemant Kaul; Mudit Saxena; Ram Kumar Kakani
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Genpact investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Genpact

When was Genpact founded?Genpact was founded in 2007.
Where is Genpact headquartered?Genpact is headquartered in India.
How many employees does Genpact have?As of today, Genpact has over 140K employees.
Who is the CEO of Genpact?Genpact's CEO is Balkrishan Kalra.
Is Genpact publicly listed?Yes, Genpact is a public company listed on NYSE.
What is the stock symbol of Genpact?Genpact trades under G ticker.
When did Genpact go public?Genpact went public in 2007.
Who are competitors of Genpact?Genpact main competitors include Teleperformance, L&T Technology Services, Sagility, Firstsource Solutions, MyEG, Amano, Concentrix, eClerx Services, Jack Henry & Associates, Intertek.
What is the current market cap of Genpact?Genpact's current market cap is $5B.
What is the current revenue of Genpact?Genpact's last 12 months revenue is $5B.
What is the current revenue growth of Genpact?Genpact revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of Genpact?Current revenue multiple of Genpact is 1.1x.
Is Genpact profitable?Yes, Genpact is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Genpact?Genpact's last 12 months EBITDA is $964M.
What is Genpact's EBITDA margin?Genpact's last 12 months EBITDA margin is 18%.
What is the current EV/EBITDA multiple of Genpact?Current EBITDA multiple of Genpact is 6.0x.
What is the current FCF of Genpact?Genpact's last 12 months FCF is $705M.
What is Genpact's FCF margin?Genpact's last 12 months FCF margin is 14%.
What is the current EV/FCF multiple of Genpact?Current FCF multiple of Genpact is 8.2x.
How many companies Genpact has acquired to date?As of May 2026, Genpact has acquired 17 companies.
What was the largest acquisition by Genpact?$271M acquisition of Rightpoint on 15th October 2019 was the largest M&A Genpact has done to date.
What companies Genpact acquired?Genpact acquired Rightpoint, Enquero, Pharmalink Consulting, RAGE Frameworks, BrightClaim, Strategic Sourcing Excellence, TandemSeven, PNMsoft, Commonwealth Informatics, Endeavour Software Technologies, and 7 other companies.
In how many companies Genpact has invested to date?As of May 2026, Genpact has invested in 1 company.
What was the last Genpact investment?On 29th July 2016 Genpact invested in Medinfi Healthcare, participating in a $200K Angel round, alongside Evan Lim, Hemant Kaul, Mudit Saxena, and Ram Kumar Kakani.
In what companies Genpact invested in?Genpact invested in Medinfi Healthcare.

See public comps similar to Genpact

Lists including Genpact

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial